Transcat, Inc. (NASDAQ:TRNS) Shares Acquired by Champlain Investment Partners LLC

Champlain Investment Partners LLC raised its stake in Transcat, Inc. (NASDAQ:TRNS - Free Report) by 35.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 555,650 shares of the scientific and technical instruments company's stock after acquiring an additional 146,150 shares during the period. Champlain Investment Partners LLC owned 5.97% of Transcat worth $58,754,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently bought and sold shares of the stock. State Street Corp lifted its holdings in shares of Transcat by 8.1% in the 3rd quarter. State Street Corp now owns 207,230 shares of the scientific and technical instruments company's stock valued at $25,027,000 after purchasing an additional 15,514 shares during the last quarter. Barclays PLC grew its position in shares of Transcat by 393.0% during the third quarter. Barclays PLC now owns 15,130 shares of the scientific and technical instruments company's stock worth $1,826,000 after acquiring an additional 12,061 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Transcat by 5.4% in the 3rd quarter. Geode Capital Management LLC now owns 217,473 shares of the scientific and technical instruments company's stock valued at $26,269,000 after acquiring an additional 11,106 shares during the period. Virtu Financial LLC raised its position in Transcat by 127.0% in the 3rd quarter. Virtu Financial LLC now owns 4,136 shares of the scientific and technical instruments company's stock valued at $499,000 after purchasing an additional 2,314 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its stake in Transcat by 8.8% during the 3rd quarter. Principal Financial Group Inc. now owns 4,611 shares of the scientific and technical instruments company's stock worth $557,000 after purchasing an additional 373 shares during the period. Institutional investors and hedge funds own 98.34% of the company's stock.

Insider Activity

In related news, Director Craig D. Cairns purchased 1,200 shares of the company's stock in a transaction on Friday, January 31st. The stock was bought at an average price of $77.02 per share, with a total value of $92,424.00. Following the completion of the transaction, the director now owns 1,910 shares of the company's stock, valued at approximately $147,108.20. This represents a 169.01 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 2.30% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. StockNews.com cut shares of Transcat from a "hold" rating to a "sell" rating in a report on Wednesday, February 5th. Oppenheimer cut Transcat from an "outperform" rating to a "market perform" rating in a research note on Wednesday, January 29th. Northland Securities reissued a "market perform" rating and issued a $85.00 price objective (down from $110.00) on shares of Transcat in a research note on Wednesday, January 29th. Finally, HC Wainwright lowered their target price on shares of Transcat from $126.00 to $106.00 and set a "buy" rating on the stock in a report on Wednesday, January 29th. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $111.50.

Transcat Price Performance

Shares of TRNS traded up $1.98 on Tuesday, reaching $85.53. The stock had a trading volume of 28,976 shares, compared to its average volume of 73,516. The firm has a 50-day moving average of $77.09 and a 200 day moving average of $95.23. The firm has a market capitalization of $796.20 million, a PE ratio of 46.23 and a beta of 0.67. Transcat, Inc. has a twelve month low of $67.56 and a twelve month high of $147.12. The company has a quick ratio of 1.98, a current ratio of 2.42 and a debt-to-equity ratio of 0.14.

Transcat (NASDAQ:TRNS - Get Free Report) last released its quarterly earnings results on Monday, January 27th. The scientific and technical instruments company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.07. Transcat had a return on equity of 7.23% and a net margin of 6.22%. During the same quarter in the prior year, the firm posted $0.56 earnings per share. Sell-side analysts expect that Transcat, Inc. will post 2.3 EPS for the current year.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.